Trusopt

This page contains recent news articles, when available, and an overview of Trusopt but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Overview:

Trusopt
(when available)

Pharmacology and use:
Dorzolamide is topical carbonic anhydrase inhibitor. Dorzolamide is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers. For the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma

Mechanism Of Action:
Dorzolamide is a sulfonamide and a human carbonic anhydrase II inhibitor. Inhibition of carbonic anhydrase II in the ciliary processes of the eye decreases aqueous humor secretion, presumably by slowing the formation of bicarbonate ions with subsequent reduction in sodium and fluid transport.

News Articles on Dorzolamide

Health care reform needs to extend to drug prices  -  ‎Oct 29, 2009‎
American Journal of Ophthalmology showed the yearly cost in 2006 for a patient on three brand-name eyedrops (Xalatan, Alphagan P and Trusopt) was $1933. ... Modesto Bee

Fitch Downgrades Merck and Upgrades Schering-Plough to 'A+' Following Merger ...  -  ‎Nov 4, 2009‎
...for the LTM period at the end of the third quarter as the company has not yet recovered from the patent losses of Fosamax and Trusopt/Cosopt in 2008. ... Earthtimes (press release)

Merck Announces Third-Quarter 2009 Financial Results  -  ‎Oct 22, 2009‎
INVANZ, ISENTRESS, MAXALT, PRIMAXIN, PROPECIA, PROSCAR, STOCRIN, TIMOPTIC/TIMOPTIC XE, TREDAPTIVE, TRUSOPT, VASOTEC/VASERETIC, ZOCOR and ZOLINZA. ... Reuters

09:47 GAZZETTA UFFICIALE: SOMMARIO (4)  -  ‎Nov 11, 2009‎
Variazione di tipo II all'autorizzazione, secondo procedura di mutuo riconoscimento, del medicinale per uso umano "Trusopt". ... ANSA Valle d'Aosta

US Appeals Court favors Merck in patent fight over eye drug  -  Mar 29, 2007
Hi-Tech, Amityville, NY, had argued that the patent for Trusopt had already expired in ... Merck's combined sales of Trusopt and a related drug, Cosopt, ... MarketWatch

Business News in Brief  -  Dec 5, 2006
Trusopt is used to treat eye conditions called open-angle glaucoma or ocular ... Trusopt and a related drug called Cosopt generated $517.8 million in sales ... $2.95 - Philadelphia Inquirer - NewsBank

United States Federal Circuit Court of Appeals Reports - MERCK & CO.,...  -  Jun 4, 2007
I. BACKGROUND Merck & Co, Inc. ("Merck") is the inventor of TRUSOPT®, a drug used to treat ... The Orange Book shows that the `413 patent covers TRUSOPT®. ... Pay-Per-View - United States Federal Circuit Court of... - Loislaw

Volumetric colour Doppler imaging: a useful tool for the determination...  -  Jun 3, 2005
Dorzolamide was obtained in the form of Trusopt ® from MSD-Chibret, Munich, Germany. Trusopt ® contains 22.26 mg dorzolamide hydrochloride per 1 ml. ... Nature.com

Glaucoma and ADHD reimbursement criticised  -  Jan 18, 2007
Consequently, the reimbursement limit for Trusopt has decreased by approx. 30%. ... Patients who continue using Trusopt will have to pay more from their own ... Polish Market

Pharmacology; Novel dorzolamide formulation has improved …  -  Apr 22, 2005
To "increase the topical bioavailability of the drug from Trusopt, the contact time of the drug with the eye surface is increased by increasing the ... Pay-Per-View - Drug Week - Factiva, from Dow Jones

United States Federal Circuit Court of Appeals Reports - MERCK v. …  -  Aug 21, 2008
I. BACKGROUND Appellee Merck manufactures and sells glaucoma medications Trusopt® and Cosopt®. Each of these medications received approval by the Food and ... Pay-Per-View - United States Federal Circuit Court of... - Loislaw

Press Release: Prasco to Distribute Generic Forms of Dorzolamide …  -  Oct 28, 2008
Maleate and Dorzolamide Hydrochloride Ophthalmic Solutions (Comparable to Merck's COSOPT(R) and TRUSOPT(R) Ophthalmic Solutions). from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research

Federal Register 2005 - 70 FR 15636 Summaries of Medical and Clinical  -  Mar 28, 2005
The summaries of medical and clinical pharmacology reviews of pediatric studies conducted for PARAPLATIN (carboplatin), TRUSOPT (dorzolamide), ... Pay-Per-View - Federal Register 2005 - Loislaw

Allergan Sues India's Exela to Block Generic Eye Drug  -  Mar 30, 2007
Alphagan P competes with Johnson & Johnson's Trusopt glaucoma treatment. Yesterday, Johnson & Johnson won an appeals court ruling that blocks generic ... Bloomberg

Hi-Tech Pharmacal Receives Final Approval for Dorzolamide Ophthalmic ...  -  Oct 28, 2008
Trusopt® had sales of $45 million for the 12 months ended June 2008 according to IMS. Hi-Tech plans to launch generic dorzolamide ophthalmic solution 2% ... International Business Times

AHL Highlights Recent Developments  -  Dec 7, 2006
Merck: New Jersey-based Merck filed a lawsuit seeking to block Canada-based Apotex from marketing a generic version of Merck's glaucoma treatment Trusopt, ... Pay-Per-View - American Health Line - Factiva, from Dow Jones

United States: Dismissal Of Declaratory Judgment Counterclaims In …  -  Aug 10, 2008
In the course of obtaining US Food and Drug Administration (FDA) approval for its glaucoma medications Trusopt® and Cosopt®, Merck informed the FDA that ... Mondaq News Alerts - Mondaq News Alerts (Registration)

Costs Rising to Make Intraocular Pressure Fall  -  Dec 28, 2007
However, betaxolol 0.25%, brinzolamide (Azopt), dorzolamide (Trusopt), and generic carteolol 1.0% were usually slightly underfilled. ... MedPage Today

Terminally Disclaimed Patent Eligible For Hatch-Waxman Patent Term …  -  May 16, 2007
4797413, covering dorzolamide, the active ingredient in TRUSOPT[R], ... The FDA approved Merck's New Drug Application (NDA) for TRUSOPT[R] in 1994, ... Free with registration - Mondaq Business Briefing - AccessMyLibrary.com

Dismissal Of Declaratory Judgment Counterclaims In Fosamax Case …  -  Oct 8, 2008
In the course of obtaining U.S. Food and Drug Administration (FDA) approval for its glaucoma medications Trusopt[R] and Cosopt[R], Merck informed the FDA ... $9.94 - Mondaq Business Briefing - Alacra Store

Adjunctive brimonidine results in greater IOP lowering: study finds...  -  Sep 1, 2007
Allergan) and dorzolamide 2% (Trusopt, Merck) as adjuncts to latanoprost 0.005% (Xalatan, Pfizer) show the addition of either agent results in further ... Free with registration - Ophthalmology Times - AccessMyLibrary.com

Drug patent expirations (2007-2009).  -  Apr 2, 2007
12, 2008 Casodex Oct. 1, 2008 Trusopt Oct. 28, 2008 Zerit Dec. 24, 2008 Lamictal Jan. 22, 2009 Vexol Jan. 22, 2009 Avandia Feb. 28, 2009 Topamax March 26, ... $4.95 - Drug Topics - ECNext

Business notebook  -  Dec 5, 2006
Cease and desist: Merck & Co. sued Canada's Apotex Inc. seeking to prevent sales of a generic form of the glaucoma treatment Trusopt. ... Boston Globe

Bulk buying might cut cost  -  Feb 27, 2006
Here are some examples: Travatan eye drops from $2.50 to $20, Trusopt eye drops from $5.60 to $20, and Zocor 20 mg from $2.50 to $60. ... Pay-Per-View - Austin American-Statesman - NewsBank

The Columbus Dispatch - Local/State | The Columbus Dispatch  -  Dec 5, 2005
Trusopt, Azopt, Xalatan and Lumigan are glaucoma medicines that can be used in place of timolol. Q: My doctor has me on hydrocortisone because of ... Columbus Dispatch

Glaucoma In-Depth Report  -  Sep 13, 2006
Topical forms are dorzolamide (Trusopt) and brinzolamide (Azopt). (Oral CAIs are available and more effective, but they have severe side effects and are ... New York Times

Recent Actions by the Food and Drug Administration  -  Mar 28, 2005
The labeling of dorzolamide (Trusopt ® ; Merck) was modified in April 2004 to include efficacy and safety data in children. Dorzolamide reduces intraocular ... Medscape

ASK AN EXPERT  -  Jul 17, 2008
Examples include dorzolamide (Trusopt) and brinzolamide (Azopt). Frequent urination and a tingling sensation in the fingers and toes are possible side ... CNN International

Glaucoma creeps up on more Americans  -  Nov 4, 2007
Although there is little damage to her optic nerve, she takes Xalatan in both eyes and Trusopt in her right (she has higher pressure in her right eye than ... USA Today

Glaucoma and vision 2020  -  Oct 15, 2008
Carbonic anhydrase inhibitors like dorzolamide (Trusopt) and brinzolamide (Azopt). A tablet form exists as acetazolamide (Diamox), but it has greater side ... Jamaica Gleaner

GlaxoSmithKline Seeks Approval for Cervical Vaccine  -  Mar 29, 2007
The company, the third-biggest US drugmaker, today won an appeals court ruling to block a generic version of the glaucoma treatment Trusopt. ... Bloomberg

Merck To Offer Discounted Drugs To Uninsured  -  Apr 19, 2005
Other drugs covered by the program include Cosopt, Emend, Fosamax, Maxalt, Maxalt-MLT, Proscar and Trusopt. A rival discount card for the uninsured from 10 ... WBAL Channel.com

on Hi-Tech Pharmacal Co., Inc.  -  Jul 12, 2006
We submitted five ANDA's, including Paragraph IV submissions for Merck's Trusopt and Cosopt , and our pipeline has never been more robust." ... Free with registration - M2 Presswire - AccessMyLibrary.com

Cost of glaucoma medications may impact treatment  -  Dec 30, 2007
The two carbonic anhydrase inhibitors, Azopt and Trusopt, yielded similar economic profiles. The generic selective a2-agonist brimonidine tartrate 0.2% ... The Hindu

Making profs' research pay off  -  Oct 5, 2005
Licensing a blockbuster like the glaucoma drug Trusopt has been for University of Florida, the state leader when it comes to turning research into revenue. ... sptimes.com

Chemist Wins National Award For Contributions In Medicinal Chemistry  -  Mar 21, 2006
Out of this effort came Zocor®, a statin widely prescribed for lowering cholesterol, and Trusopt®, a carbonic anhydrase inhibitor used to treat glaucoma. ... Medical News Today - Medical News Today (press release)

Florida Bets House On Oregon While Short-Changing Its Own  -  Jan 27, 2008
The glaucoma drug Trusopt, also discovered at UF, brought in another $20 million annually. The biggest royalty pay day was at Florida State University, ... Brandon News and Tribune

Business News in Brief  -  Mar 30, 2007
Inc. from selling a generic version of the glaucoma treatment Trusopt until April 2008. The US Court of Appeals for the Federal Circuit said Merck was ... $2.95 - Philadelphia Inquirer - NewsBank

Stocks to watch!  -  Sep 25, 2006
Proscar, a urology product used for treatment of symptomatic benign prostate enlargement; Cosopt and Trusopt, which are ophthalmological products; ... Free with registration - M2 Presswire - AccessMyLibrary.com

Dorzolamide May Be Effective, Well Tolerated for Pediatric Glaucoma  -  Sep 13, 2005
..."The topical carbonic anhydrase inhibitor dorzolamide hydrochloride (Trusopt; Merck & Co, Inc, Whitehouse Station, NJ) has been studied in pediatric ... Medscape

Comparison study: brimonidine fares well as add-on therapy: addition...  -  Jan 15, 2008
2% (Trusopt, Merck) or brinzolamide 1% (Azopt, Alcon Laboratories) as an adjunctive medication in glaucoma therapy, according to a recent study. ... Free with registration - Ophthalmology Times - AccessMyLibrary.com

SLT an evolutionary approach to glaucoma: selective laser, argon...  -  Aug 1, 2005
Step 4: If the target IOP is not met, but the third medication is deemed effective: dorzolamide (Trusopt, Merck), brinzolamide (Azopt, Alcon Laboratories), ... Free with registration - Ophthalmology Times - AccessMyLibrary.com

Hi-Tech Pharmacal Co.(RX/GENERIC DRUGS--Profiles)  -  Sep 25, 2006
...s Trusopt and Cosopt. However, the company is not content to rest on its laurels, and its pipeline has never been more robust. Hi-Tech currently has 12 ... Free with registration - Chain Drug Review - AccessMyLibrary.com

Chemist wins national award for contributions in medicinal chemistry  -  Mar 17, 2006
Out of this effort came Zocor®, a statin widely prescribed for lowering cholesterol, and Trusopt®, a carbonic anhydrase inhibitor used to treat glaucoma. ... eurekalert.org

UF official: Research aids Ocala  -  Mar 27, 2008
Commercial products that began as UF research products include the glaucoma drug Trusopt, Sentricon termite treatment, and of course, the legendary Gatorade ... $2.95 - Ocala Star-Banner - NewsBank

Торги в СШÐ? завершилиÑ?ÑŒ повышением котировок на фоне роÑ?та Ñ?Ñ‚  -  Mar 30, 2007
запретил реализацию более дешевой верÑ?ии офтальмологичеÑ?кого препарата Trusopt до иÑ?течениÑ? Ñ?роков патентов компании на Ñ?тот препарат в Ñ?ледующем году. ... Прайм-ТÐ?СС

Federal Register 2005 - 70 FR 30126 Pediatric Advisory Committee; …  -  May 25, 2005
...ciprofloxacin (CIPRO), tolterodine (DETROL LA), leflunomide (ARAVE), paricalcitol (ZEMPLAR), zolmitriptan (ZOMIG), dorzolamide (TRUSOPT). ... Pay-Per-View - Federal Register 2005 - Loislaw

Press Release: A Comprehensive Competitor Close-Up for Merck & …  -  Dec 4, 2008
...and Cosopt/Trusopt (dorzolamide hydrochloride; ophthalmic) in October 2008. Merck is taking aggressive action to counteract its challenges. ... Pay-Per-View - M2 Presswire - HighBeam Research

New Medications for Osteoporosis.(Arzoxifene from Eli Lilly)(Brief...  -  Feb 1, 2005
There are promising new medications, too. One is Alphagan from Allergan.Others: Xalatan from Pharmacia & Upjohn; Trusopt from Merck All in eye ... ... Pay-Per-View - Kiplinger's Retirement Report - HighBeam Research

Article: Screen obese, diabetic women for incontinence.(Women's...  -  Aug 15, 2006
528 63.95% -10782 -154 SUI -$0.70 -4.92% 27720 ... Januvia and Janumet for type 2 diabetes; Cosopt and Trusopt, the ophthalmological ... ... Pay-Per-View - Family Practice News - HighBeam Research

Market Commentary on Merck & Co. Inc.  -  Jun 12, 2007
...an atherosclerosis product; Primaxin and Cancidas, anti-bacterial/anti-fungal products; Cosopt and Trusopt, the ophthalmological products; Proscar, ... Free with registration - M2 Presswire - AccessMyLibrary.com

MEDICARE MAILBAG: Bulk orders one option when drug costs rise  -  Feb 25, 2006
Here are some examples: Travatan eye drops from $2.50 to $20, Trusopt eye drops from $5.60 to $20, and Zocor 20 mg from $2.50 to $60. ... Pay-Per-View - Atlanta Journal-Constitution - NewsBank

UF Launches Project To Bridge The Regeneration Gap.  -  Apr 2, 2007
Maren spent most of his career at UF's College of Medicine and his research led to the development of Trusopt, an important drug for the treatment of ... Free with registration - Space Daily - AccessMyLibrary.com

M2 PRESSWIRE-2 October 2006-The Street Review: Investor Alert!(C) …  -  Oct 2, 2006
Proscar, a urology product used for symptomatic benign prostate enlargement; Cosopt and Trusopt, which are ophthalmological products; Maxalt, ... $4.95 - M2 Presswire - ECNext

El precio de los fármacos para el glaucoma puede influir en el...  -  Jan 2, 2008
En relación con los inhibidores de la anhidrasa carbónica, tanto los fármacos Azopt como Trusopt han dado resultados similares desde el punto de vista ... Diario Médico - Diario Médico (Suscripción)

SLT comparable with medical therapy for open-angle glaucoma: added …  -  Jan 15, 2007
In the third step, brimonidine tartrate (Alphagan, Allergan) was added or substituted, and in the fourth step, dorzolamide (Trusopt, Merck), ... Free with registration - Ophthalmology Times - AccessMyLibrary.com

Current Research on Merck & Co. Inc.  -  Jun 18, 2007
...an atherosclerosis product; Primaxin and Cancidas, anti-bacterial/anti-fungal products; Cosopt and Trusopt, the ophthalmological products; Proscar, ... Free with registration - M2 Presswire - AccessMyLibrary.com

Topical dorzolamide shows promise for macular edema  -  Nov 10, 2007
Topical dorzolamide (Trusopt, Merck) may offer hope for the treatment of macular edema in some patients with retinitis pigmentosa and X-linked retinoschisis ... Ophthalmology Times

Glaucoma patient complains of foreign body sensation, decreased vision  -  Oct 15, 2007
His ocular medications included pilocarpine 1% three times a day in the right eye, Timoptic 0.5% (timolol) once a day in the right eye and Trusopt 2% ... OSN SuperSite

Glaucoma stealing sight from more Americans  -  Nov 20, 2007
Although there is little damage to her optic nerve, she takes Xalatan in both eyes and Trusopt in her right (she has higher pressure in her right eye than ... Sauk Valley Newspapers

Hi-Tech Pharmacal Co.(RX/GENERIC DRUGS--Profiles) | Article from …  -  Sep 25, 2006
...s Trusopt and Cosopt. However, the company is not content to rest on its laurels, and its pipeline has never been more robust. Hi-Tech currently has 12 ... Pay-Per-View - Chain Drug Review - HighBeam Research

メルクã€?緑内障薬ã?®ç‰¹è¨±è¨´è¨Ÿã?§ã‚¢ãƒ?テックスã?«å‹?訴  -  Aug 25, 2008
...米製薬大手メルク(Merck)ã?¨åŠ ã‚¢ãƒ?テックス(Apotex)ã?®é–“ã?®ã€?緑内障治療薬「 トルソプトã€?(Trusopt)ã?¨ã€Œã‚³ã‚½ãƒ—トã€?(Cosopt)ã?®å¾Œç™ºè–¬ã‚’ã‚?ã??る訴訟ã?§ã€?米連邦巡回控訴 ... IP NEXT ニュース

Forum Augenheilkunde: Grüner Star - Onmeda: Medizin & Gesundheit  -  Jan 9, 2008
Ich habe grünen Star in Anfangsstadium das wurde jetzt bei meinen Aufenthalt im kh festgestellt die Therapie fängt mit Trusopt an 3 x tgl.. ... Onmeda

Press Release: Current Research on Merck & Co. Inc. - M2 Presswire | ...  -  Jun 18, 2007
...an atherosclerosis product; Primaxin and Cancidas, anti-bacterial/anti-fungal products; Cosopt and Trusopt, the ophthalmological products; Proscar, ... Pay-Per-View - M2 Presswire - HighBeam Research

Press Release: Merck & Co., Inc. Announce FDA Approves JANUMET(TM …  -  Apr 2, 2007
M2 Presswire; January 30, 2009 ; 700+ words ... ... and Trusopt, the ophthalmological products; Primaxin and Cancidas, the anti bacterial/anti fungal ... Pay-Per-View - M2 Presswire - HighBeam Research

UF'S NOT-SO-SECRET TECH-DEVELOPMENT WEAPON  -  Jan 8, 2007
...such as Merck & Co., which licenses the glaucoma treatmen Trusopt for $20 million a year. But if Big Pharma wasn't interested, the science was shelved. ... Pay-Per-View - Palm Beach Post - NewsBank

FDA Approved Treatment For Chronic Arthritis Pain.  -  Apr 12, 2007
...an atherosclerosis product; Primaxin and Cancidas, anti-bacterial/anti-fungal products; Cosopt and Trusopt, the ophthalmological products; Proscar, ... $4.95 - M2 Presswire - ECNext

In- Depth Research on Merck & Co. Inc.  -  Apr 13, 2007
...an atherosclerosis product; Primaxin and Cancidas, anti-bacterial/anti-fungal products; Cosopt and Trusopt, the ophthalmological products; Proscar, ... $4.95 - M2 Presswire - ECNext

Press Release: Market Commentary on Merck & Co. Inc. - M2 Presswire |...  -  Jun 28, 2007
...an atherosclerosis product; Primaxin and Cancidas, anti-bacterial/anti-fungal products; Cosopt and Trusopt, the ophthalmological products; Proscar, ... Pay-Per-View - M2 Presswire - HighBeam Research

Keep eyedrops where they're needed.(Brief article) | Article from...  -  Mar 1, 2007
Some common eye drops for glaucoma include Alphagan, Trusopt ... like to investigate how much some of the eye drops can lower systemic blood pressure. ... Pay-Per-View - Saturday Evening Post - HighBeam Research

Hi-Tech Pharmacal Co.  -  Sep 17, 2007
...equivalent of GlaxoSmithKline's Flonase, which the company submitted to the FDA in February 2005, and submissions for Merck's Trusopt and Cosopt. ... $9.94 - Chain Drug Review - Alacra Store

FDA: Rotavirus Vaccine May Harm Infants | Article from AP Online | …  -  Feb 13, 2007
4 billion Cosopt/Trusopt eyedrops for glaucoma $781 million Primaxin intravenous antibiotic $760 million RotaTeq rotavirus vaccine $665 million _______ ... Pay-Per-View - Associated Press/AP Online - HighBeam Research

Article: FDA: Rotavirus Vaccine May Harm Infants - AP Online |...  -  Feb 13, 2007
4 billion Cosopt/Trusopt eyedrops for glaucoma $781 million Primaxin intravenous antibiotic $760 million RotaTeq rotavirus vaccine $665 million _______ ... Pay-Per-View - Associated Press/AP Online - HighBeam Research

Merck faces expiry pressure ahead.(WALL STREET CHOICE) | Article …  -  Oct 1, 2007
However, the company still faces pressure from the upcoming patent expiries of Fosamax and Trusopt in 2008, Primaxin in 2009 and Cozaar in 2010. ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

Firms examine venture capital *** Northeast, Calif. have lion's share  -  Oct 25, 2007
At Florida, three products generate more than 90 percent of the school's $43 million in licensing fees: Sentricon, a termite treatment; Trusopt, a glaucoma ... Pay-Per-View - The Advocate - ProQuest Archiver

FDA: Rotavirus Vaccine May Harm Infants | Article from AP Online | …  -  Feb 14, 2007
4 billion Cosopt/Trusopt eyedrops for glaucoma $781 million Primaxin intravenous antibiotic $760 million RotaTeq rotavirus vaccine $665 million _______ ... Pay-Per-View - Associated Press/AP Online - HighBeam Research

FDA: Rotavirus Vaccine May Harm Infants | Article from AP Online | …  -  Feb 13, 2007
4 billion Cosopt/Trusopt eyedrops for glaucoma $781 million Primaxin intravenous antibiotic $760 million RotaTeq rotavirus vaccine $665 million _______ ... Pay-Per-View - Associated Press/AP Online - HighBeam Research

Re: Glaukom und nebenwirkung von Tropfen  -  Sep 25, 2007
Nach Feststellung des hohen Augendrucks vor 4 Wochen wurde zwei Tage später eine HRT gemacht, und ich erhielt Trusopt, die am nächsten Tag den Druck gesenkt ... Onmeda

Patton v. Continental Casualty Co., No. 04-0220 (EDPa. 03/31/2005)  -  Mar 31, 2005
In his letter to Dr. Gabriel of January 25, 2002, he noted that Patton was using Trusopt 2% and Timoptic 1/2 % on both eyes twice per day. ... $2.95 - U.S. District Courts - VersusLaw

Brand Names/Synonyms:
Trusopt is also known by the following brand names and/or synonymsCHEMBANK1829; Dorzolamide; Trusopt

Drug Category:
Trusopt is categorized under the following by the FDA: Antihypertensive Agents; Carbonic Anhydrase Inhibitors; ATC:S01EC03

Dosage Forms:
Solution

Absorption:
Not Available

Interactions:
[an error occurred while processing this directive]



Chemical IUPAC Name:
2-ethylamino-4-methyl-5,5-dioxo-5$l^{6},7-dithiabicyclo[4.3.0]nona-8,10-diene-8-sulfonamide





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy